Clarivate (CCC) stock price, revenue, and financials

Clarivate market cap is $17.5 b, and annual revenue was $1.25 b in FY 2020

$17.5 B

CCC Mkt cap, 01-Apr-2021

$1.3 B

Clarivate Revenue FY, 2020
Clarivate Net income (FY, 2020)-311.9 M
Clarivate EBIT (FY, 2020)2.8 M
Clarivate Cash, 31-Dec-2020257.7 M
Clarivate EV20.9 B
Get notified regarding key financial metrics and revenue changes at ClarivateLearn more
Banner background

Clarivate Revenue Breakdown

Embed Graph

Clarivate revenue breakdown by business segment: 17.4% from Transaction Revenues and 82.6% from Subscription Revenues

Clarivate revenue breakdown by geographic segment: 28.6% from Europe/Middle East/Africa, 47.5% from Americas and 23.9% from APAC

Clarivate Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

917.6m968.5m974.3m1.3b

Revenue growth, %

6%1%

Cost of goods sold

394.2m396.5m346.5m

Gross profit

523.4m572.0m627.8m

Gross profit Margin, %

57%59%64%

Sales and marketing expense

7.1m

General and administrative expense

343.1m369.4m368.7m523.6m

Operating expense total

670.4m677.7m670.9m583.1m

Depreciation and amortization

228.5m237.2m200.5m

EBIT

(147.0m)(105.7m)(43.1m)2.8m

EBIT margin, %

(16%)(11%)(4%)0%

Interest expense

138.2m130.8m157.7m111.9m

Pre tax profit

(285.2m)(236.5m)(200.8m)(314.2m)

Income tax expense

(21.3m)5.6m10.2m(2.3m)

Net Income

(263.9m)(242.2m)(211.0m)(311.9m)

EPS

(160.8)(147.1)(0.8)

Clarivate Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

53.2m25.6m76.1m257.7m

Accounts Receivable

317.8m331.3m333.9m737.7m

Prepaid Expenses

28.4m31.0m40.7m58.3m

Current Assets

443.9m408.6m493.1m1.3b

PP&E

23.0m20.6m18.0m36.3m

Goodwill

1.3b1.3b1.3b6.3b

Total Assets

4.0b3.7b3.8b15.2b

Accounts Payable

60.8m38.4m26.5m82.0m

Short-term debt

45.3m60.3m31.1m28.6m

Current Liabilities

661.1m643.7m651.0m1.6b

Long-term debt

2.0b1.9b1.7b3.5b

Total Debt

2.0b2.0b1.7b3.6b

Total Liabilities

2.7b2.7b2.4b5.9b

Common Stock

16.0k16.0k10.0b

Additional Paid-in Capital

1.7b1.7b2.2b

Retained Earnings

(390.1m)(632.3m)(843.2m)(1.2b)

Total Equity

1.3b1.1b1.4b9.3b

Debt to Equity Ratio

1.6 x1.9 x1.3 x0.4 x

Debt to Assets Ratio

0.5 x0.5 x0.5 x0.2 x

Financial Leverage

3.1 x3.5 x2.8 x1.6 x

Clarivate Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(263.9m)(242.2m)(211.0m)(311.9m)

Depreciation and Amortization

228.5m237.2m200.5m303.2m

Accounts Receivable

43.1m(50.9m)(593.0k)29.9m

Accounts Payable

(39.7m)(18.1m)(13.8m)(2.9m)

Cash From Operating Activities

6.7m(26.1m)117.6m263.5m

Purchases of PP&E

(107.7m)

Capital Expenditures

(37.8m)(45.4m)(69.8m)

Cash From Investing Activities

(40.2m)11.9m(140.9m)(3.0b)

Long-term Borrowings

(15.4m)(76.7m)(691.5m)(125.0m)

Cash From Financing Activities

22.8m(32.6m)75.2m2.9b

Net Change in Cash

(7.5m)(52.0m)50.9m192.9m

Interest Paid

115.2m121.9m101.2m97.5m

Income Taxes Paid

14.7m13.2m29.2m27.6m

Free Cash Flow

(31.1m)(71.5m)47.7m

Clarivate Ratios

USDFY, 2017

Revenue/Employee

505.0k

Debt/Equity

1.6 x

Debt/Assets

0.5 x

Financial Leverage

3.1 x

Clarivate Operating Metrics

Clarivate's Enterprise Customers was reported to be 40 k in FY, 2019.
FY, 2017Q1, 2018Q2, 2018FY, 2018Q1, 2019Q2, 2019Sep, 2019Q3, 2019FY, 2019Q1, 2020Q2, 2020Q3, 2020

Annual Contract Value

$737.5 m$731.2 m$755.1 m$764.4 m$765.1 m$782.6 m$788.7 m$793.73 m$820.25 m$852.84 m$860.93 m

Enterprise Customers

40 k40 k

Trademarks

556644

Trademark Applications

174276

Domain Names Registered

2.68 k2.85 k

Patents Issued

5668

Patent Applications

5858

Journal Titles Reviewed Annually, Web of Science

3 k

Drug Program Records, Cortellis

70 k73 k

Clinical Trial Records, Cortellis

300 k340 k340 k

Patent Publications in Database, The Derwent World Patents Index

80 m80 m

Patent and Trademark Offices in Database, The Derwent World Patents Index

5050

Records, Web of Science

161 m

Journals Indexed, Web of Science

34 k

Cited References, Web of Science

1.7 b

Molecular Interactions, Cortellis

2 m

Pharmacology Data Points, Cortellis

2.9 m

Drugs and Biologics Records, Cortellis

560 k

Deals, Cortellis

95 k

Company Profiles, Cortellis

177 k

Searches Run Yearly, Derwent

14 m

Patent Applications Examined Yearly, Derwent

3 m

Trademark Databases, CompuMark

186180

Industrial Design Databases, CompuMark

1715

Company Name Databases, CompuMark

212

Pharma In-Use Databases, CompuMark

7270

Codes and Standards, Techstreet

550 k

Users, Techstreet

130 k

Standards Publishers, Techstreet

150

Corporate Domain Names (MarkMonitor)

1.3 m

Countries

170

Clarivate Employee Rating

3.7661 votes
Culture & Values
3.5
Work/Life Balance
3.9
Senior Management
3.3
Salary & Benefits
3.6
Career Opportunities
3.3
Source